| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_ff_promoter_n_PM_12_113_8 |
 |
 |
1 |
0.5 |
3.08E-05 |
RELA,
COL5A3 |
acetaldehyde metabolic process [BP],
extracellular matrix structural constituent [MF] |
| CG_ff_promoter_n_PM_12_73_10 |
 |
 |
2 |
1.0 |
3.10E-05 |
GAS6,
ITIH4 |
endopeptidase inhibitor activity [MF],
negative regulation of dendritic cell apoptotic process [BP],
negative regulation of fibroblast apoptotic process [BP],
virion attachment, binding of host cell surface receptor [BP],
negative regulation of interleukin-1 secretion [BP],
negative regulation of endopeptidase activity [BP],
positive regulation of glomerular filtration [BP],
cellular response to vitamin K [BP],
negative regulation of protein import into nucleus, translocation [BP],
viral entry into host cell via membrane fusion with the plasma membrane [BP],
negative regulation of interleukin-6 secretion [BP],
negative regulation of renal albumin absorption [BP],
negative regulation of oligodendrocyte apoptotic process [BP],
hematopoietic stem cell migration to bone marrow [BP] |
| CG_ff_promoter_n_PM_14_62_12 |
 |
 |
3 |
1.0 |
4.60E-05 |
ISYNA1 |
inositol-3-phosphate synthase activity [MF] |
| CG_ff_promoter_n_PM_12_127_4 |
 |
 |
1 |
0.5 |
1.60E-04 |
PKD1L3 |
detection of chemical stimulus involved in sensory perception of sour taste [BP],
cellular response to acidity [BP],
sour taste receptor activity [MF] |
| CG_ff_promoter_n_PM_12_86_6 |
 |
 |
1 |
0.5 |
3.92E-05 |
MEOX2 |
limb development [BP] |
| CG_ff_promoter_n_PM_12_58_6 |
 |
 |
1 |
0.5 |
1.20E-04 |
GAMT,
LSG1,
RAC2,
SEPT12,
EOMES |
mesodermal to mesenchymal transition involved in gastrulation [BP],
guanidinoacetate N-methyltransferase activity [MF],
sperm annulus [CC],
GTP binding [MF] |
| CG_ff_promoter_n_PM_12_172_4 |
 |
 |
1 |
0.5 |
9.82E-05 |
B3GNT8,
NSUN2,
KDELR1 |
poly-N-acetyllactosamine biosynthetic process [BP],
KDEL sequence binding [MF],
tRNA (cytosine-5-)-methyltransferase activity [MF] |
| CG_ff_promoter_n_PM_12_170_3 |
 |
 |
1 |
0.5 |
8.48E-05 |
SLC13A5,
PBLD,
FTCD |
succinate transmembrane transporter activity [MF],
formimidoyltetrahydrofolate cyclodeaminase activity [MF],
glutamate formimidoyltransferase activity [MF],
isomerase activity [MF] |
| CG_ff_promoter_n_PM_12_28_5 |
 |
 |
2 |
1.0 |
4.42E-05 |
TK2 |
deoxyribonucleotide metabolic process [BP] |
| CG_ff_promoter_n_PM_12_138_10 |
 |
 |
2 |
1.0 |
5.21E-05 |
ODC1,
ENTPD4 |
putrescine biosynthetic process from ornithine [BP],
ornithine decarboxylase activity [MF],
UDP catabolic process [BP] |
| CG_ff_promoter_n_PM_12_9_8 |
 |
 |
2 |
1.0 |
1.19E-04 |
BHLHE23 |
negative regulation of retinal cell programmed cell death [BP] |
| CG_ff_promoter_n_PM_16_8_4 |
 |
 |
1 |
0.5 |
4.31E-05 |
BET1,
STX5,
MCCC1,
CUL3,
HMGCL |
vesicle fusion with Golgi apparatus [BP],
branched-chain amino acid catabolic process [BP],
ER to Golgi vesicle-mediated transport [BP],
vesicle targeting [BP],
leucine catabolic process [BP] |
| CG_ff_promoter_n_PM_14_57_13 |
 |
 |
1 |
0.5 |
2.18E-05 |
GNA13,
ARL1 |
activation of phospholipase D activity [BP] |
| CG_ff_promoter_n_PM_12_102_5 |
 |
 |
3 |
1.0 |
1.05E-04 |
JAG1,
NSMF |
apical dendrite [CC],
endocardial cushion cell development [BP] |
| CG_ff_promoter_n_PM_14_63_9 |
 |
 |
1 |
0.5 |
4.71E-05 |
IL11,
NOX1,
MEFV,
CHDH,
PPP1R9B,
HSPA5 |
cellular response to morphine [BP],
negative regulation of macrophage inflammatory protein 1 alpha production [BP],
interleukin-11 receptor binding [MF],
choline dehydrogenase activity [MF],
regulation of protein folding in endoplasmic reticulum [BP],
FADH2 metabolic process [BP] |
| CG_ff_promoter_n_PM_12_139_5 |
 |
 |
1 |
0.5 |
2.42E-05 |
SLC25A1,
BRF1,
XPC |
transcription factor TFIIIB complex [CC],
mitochondrial citrate transport [BP],
nucleotide-excision repair, DNA damage recognition [BP] |
| CG_ff_promoter_n_PM_18_14_14 |
 |
 |
2 |
1.0 |
1.43E-04 |
PIF1,
SMG6,
BRCA1 |
telomeric DNA binding [MF],
positive regulation of histone H3-K9 acetylation [BP],
positive regulation of histone H4-K16 acetylation [BP],
telomere maintenance [BP],
positive regulation of histone H4-K20 methylation [BP],
ATP-dependent 5'-3' DNA/RNA helicase activity [MF],
chromosome, telomeric region [CC] |
| CG_ff_promoter_n_PM_18_3_18 |
 |
 |
2 |
1.0 |
7.33E-05 |
NES |
positive regulation of intermediate filament depolymerization [BP] |
| CG_ff_promoter_n_PM_18_10_20 |
 |
 |
1 |
0.5 |
4.29E-05 |
SLC27A5,
HMGCL |
ketone body biosynthetic process [BP],
cellular ketone body metabolic process [BP] |
| CG_ff_promoter_n_PM_14_30_6 |
 |
 |
2 |
1.0 |
6.25E-05 |
AQP4 |
protein homooligomerization [BP],
porin activity [MF] |
| CG_ff_promoter_n_PM_12_88_6 |
 |
 |
2 |
0.5 |
8.40E-05 |
NDUFAB1 |
ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process [MF] |
| CG_ff_promoter_n_PM_20_2_70 |
 |
 |
1 |
0.5 |
4.99E-05 |
FEZF2,
LEF1 |
dentate gyrus development [BP] |
| CG_ff_promoter_n_PM_12_100_4 |
 |
 |
2 |
0.5 |
1.03E-04 |
FGF6,
FLOT1,
MAD1L1 |
sarcolemma [CC],
mitotic telophase [BP] |
| CG_ff_promoter_n_PM_18_32_11 |
 |
 |
1 |
0.5 |
1.26E-04 |
IFI6 |
negative regulation of mitochondrial depolarization [BP] |
| CG_ff_promoter_n_PM_18_2_47 |
 |
 |
2 |
1.0 |
3.71E-05 |
PALB2,
NARS,
GDF3,
PPA1,
MATK,
IKZF3,
DARS |
mesoderm development [BP],
tRNA aminoacylation for protein translation [BP] |
| CG_ff_promoter_n_PM_12_107_7 |
 |
 |
1 |
0.5 |
2.18E-04 |
MAD1L1 |
mitotic telophase [BP] |
| CG_ff_promoter_n_PM_12_4_5 |
 |
 |
2 |
1.0 |
4.36E-05 |
ALG9,
HPGD,
FADS1 |
dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF],
lipoxygenase pathway [BP],
dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF],
phospholipid biosynthetic process [BP] |
| CG_ff_promoter_n_PM_20_16_51 |
 |
 |
2 |
1.0 |
3.29E-05 |
UTP6,
RPS16,
PPAP2A,
PPAPDC1B,
AP3D1,
EIF4A3,
AP3B1 |
positive regulation of NK T cell differentiation [BP],
antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP],
rRNA processing [BP],
phosphatidate phosphatase activity [MF] |
| CG_ff_promoter_n_PM_12_92_7 |
 |
 |
2 |
1.0 |
6.57E-05 |
AKR1B1 |
glyceraldehyde oxidoreductase activity [MF] |
| CG_ff_promoter_n_PM_12_115_5 |
 |
 |
2 |
1.0 |
4.25E-05 |
TOPORS,
TP53,
APOA1,
PRKDC,
EPHA4 |
DH domain binding [MF],
response to gamma radiation [BP],
intrinsic apoptotic signaling pathway in response to DNA damage [BP],
somitogenesis [BP],
negative regulation of cell adhesion molecule production [BP],
B cell lineage commitment [BP],
DNA topoisomerase binding [MF],
T cell lineage commitment [BP],
T cell differentiation in thymus [BP],
positive regulation of Rho guanyl-nucleotide exchange factor activity [BP] |
| CG_ff_promoter_n_PM_12_117_5 |
 |
 |
2 |
0.5 |
1.05E-04 |
TNFRSF11B |
negative regulation of odontogenesis of dentin-containing tooth [BP] |
| CG_ff_promoter_n_PM_16_18_10 |
 |
 |
1 |
0.5 |
3.54E-05 |
PRKDC,
ADAM17,
NTAN1 |
T cell differentiation in thymus [BP],
B cell differentiation [BP],
protein-N-terminal asparagine amidohydrolase activity [MF] |
| CG_ff_promoter_n_PM_12_162_7 |
 |
 |
1 |
0.5 |
3.52E-05 |
PECR |
phytol metabolic process [BP],
trans-2-enoyl-CoA reductase (NADPH) activity [MF] |
| CG_ff_promoter_n_PM_12_105_9 |
 |
 |
2 |
1.0 |
2.24E-05 |
DNASE2 |
deoxyribonuclease II activity [MF] |
| CG_ff_promoter_n_PM_12_2_4 |
 |
 |
2 |
1.0 |
1.35E-05 |
HPD |
4-hydroxyphenylpyruvate dioxygenase activity [MF] |
| CG_ff_promoter_n_PM_12_96_5 |
 |
 |
1 |
0.5 |
2.50E-05 |
CBLB |
positive regulation of T cell anergy [BP] |
| CG_ff_promoter_n_PM_14_3_13 |
 |
 |
2 |
0.5 |
8.64E-05 |
IL6ST,
SNW1 |
leukemia inhibitory factor receptor activity [MF],
SMAD3-SMAD4 protein complex [CC],
interleukin-11 binding [MF],
interleukin-27 receptor activity [MF],
interleukin-6 binding [MF],
negative regulation of interleukin-6-mediated signaling pathway [BP],
interleukin-11 receptor activity [MF],
positive regulation of vitamin D receptor signaling pathway [BP],
ciliary neurotrophic factor receptor complex [CC],
interleukin-27-mediated signaling pathway [BP],
interleukin-6 receptor activity [MF] |
| CG_ff_promoter_n_PM_12_6_4 |
 |
 |
1 |
0.5 |
5.87E-05 |
C3AR1 |
C3a anaphylatoxin receptor activity [MF],
complement component C3a receptor activity [MF] |
| CG_ff_promoter_n_PM_12_70_7 |
 |
 |
2 |
1.0 |
7.50E-05 |
COL7A1 |
collagen type VII [CC] |
| CG_ff_promoter_n_PM_16_30_12 |
 |
 |
1 |
0.5 |
1.57E-04 |
NEBL,
PRKRA |
production of siRNA involved in RNA interference [BP],
cardiac muscle thin filament assembly [BP] |
| CG_ff_promoter_n_PM_16_10_21 |
 |
 |
2 |
1.0 |
2.56E-05 |
NUDT3,
UNC13D |
diphosphoinositol polyphosphate catabolic process [BP],
granuloma formation [BP],
diadenosine polyphosphate catabolic process [BP] |
| CG_ff_promoter_n_PM_12_123_6 |
 |
 |
2 |
0.5 |
2.48E-04 |
S100A14 |
positive regulation of granulocyte chemotaxis [BP] |
| CG_ff_promoter_n_PM_20_25_45 |
 |
 |
2 |
1.0 |
6.21E-05 |
CLPX,
MYH9,
LONP1,
MYH2 |
ATP-dependent peptidase activity [MF],
actomyosin contractile ring [CC] |
| CG_ff_promoter_n_PM_14_27_4 |
 |
 |
1 |
0.5 |
1.35E-04 |
NRAP,
CITED1 |
response to interleukin-9 [BP],
muscle tendon junction [CC],
response to interleukin-11 [BP] |
| CG_ff_promoter_n_PM_14_23_7 |
 |
 |
1 |
0.5 |
3.64E-05 |
GART,
RANGAP1,
TAT |
phosphoribosylformylglycinamidine cyclo-ligase activity [MF],
positive regulation of Ran GTPase activity [BP],
Ran GTPase activator activity [MF],
L-tyrosine:2-oxoglutarate aminotransferase activity [MF],
phosphoribosylglycinamide formyltransferase activity [MF],
phosphoribosylamine-glycine ligase activity [MF] |
| CG_ff_promoter_n_PM_16_39_35 |
 |
 |
2 |
1.0 |
3.39E-05 |
SNRNP200,
GSS,
ACACA,
TRANK1,
RECQL4,
EIF2AK1,
GLUD1,
BAZ1B,
GGT7,
DHX15,
BAZ2A,
TYK2,
ERN2,
NCOA2 |
histone acetyl-lysine binding [MF],
glutathione biosynthetic process [BP],
ATP binding [MF],
ligand-dependent nuclear receptor binding [MF] |
| CG_ff_promoter_n_PM_12_114_5 |
 |
 |
1 |
0.5 |
2.50E-04 |
ACD,
SLC19A2 |
thiamine transmembrane transporter activity [MF],
thiamine transmembrane transport [BP],
thiamine uptake transmembrane transporter activity [MF],
DNA polymerase binding [MF],
positive regulation of single-stranded telomeric DNA binding [BP],
thiamine transport [BP] |
| CG_ff_promoter_n_PM_20_3_27 |
 |
 |
1 |
0.5 |
7.80E-05 |
ANXA2,
AGA,
HSPD1,
TRPV4,
COL16A1,
STX1A |
positive regulation of T cell mediated immune response to tumor cell [BP],
cortical microtubule organization [BP],
collagen type XVI [CC],
N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [MF],
cellular response to acid [BP],
myosin head/neck binding [MF],
osmosensory signaling pathway [BP],
osmosensor activity [MF] |
| CG_ff_promoter_n_PM_12_166_7 |
 |
 |
1 |
0.5 |
5.68E-05 |
GLRX2,
PLOD3 |
arsenate reductase (glutaredoxin) activity [MF],
procollagen glucosyltransferase activity [MF] |
| CG_ff_promoter_n_PM_16_43_11 |
 |
 |
2 |
1.0 |
3.77E-05 |
OXER1 |
5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF],
5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF],
5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF] |
| CG_ff_promoter_n_PM_12_34_6 |
 |
 |
1 |
0.5 |
1.89E-04 |
KDM5B |
histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP] |
| CG_ff_promoter_n_PM_16_4_9 |
 |
 |
1 |
0.5 |
2.90E-05 |
UPF2,
NUP155 |
mRNA export from nucleus [BP] |
| CG_ff_promoter_n_PM_14_59_5 |
 |
 |
1 |
0.5 |
4.56E-05 |
COG4 |
Golgi vesicle prefusion complex stabilization [BP] |
| CG_ff_promoter_n_PM_12_46_8 |
 |
 |
1 |
0.5 |
1.35E-04 |
JUP,
PRLR |
prolactin signaling pathway [BP],
gamma-catenin-TCF7L2 complex [CC],
prolactin receptor activity [MF],
structural constituent of cell wall [MF] |
| CG_ff_promoter_n_PM_12_13_5 |
 |
 |
1 |
0.5 |
1.96E-05 |
IDI1 |
isopentenyl-diphosphate delta-isomerase activity [MF],
dimethylallyl diphosphate biosynthetic process [BP] |
| CG_ff_promoter_n_PM_16_41_17 |
 |
 |
2 |
1.0 |
1.16E-05 |
TRPM7,
RAF1,
UCN |
positive regulation of cAMP biosynthetic process [BP],
calcium-dependent cell-matrix adhesion [BP],
gastric emptying [BP],
positive regulation of peptidyl-serine phosphorylation [BP] |
| CG_ff_promoter_n_PM_20_21_50 |
 |
 |
2 |
1.0 |
3.83E-05 |
OTUD7B,
DHX58,
ETV5,
RARG,
GPBP1L1,
H1FX,
PRM1,
RFC2,
ZNF425,
ZNF787,
ZNF594,
ZNF836,
ZNF335,
BAZ2A,
RAD51D,
HDGF,
ZNF77,
ZNF573 |
DNA binding [MF] |
| CG_ff_promoter_n_PM_18_17_15 |
 |
 |
2 |
1.0 |
3.13E-05 |
DCAKD |
dephospho-CoA kinase activity [MF] |
| CG_ff_promoter_n_PM_12_44_6 |
 |
 |
1 |
0.5 |
4.69E-05 |
HJURP,
NAP1L4 |
nucleosome assembly [BP] |
| CG_ff_promoter_n_PM_20_23_28 |
 |
 |
2 |
1.0 |
4.58E-05 |
DAPK3,
SYNCRIP |
negative regulation of translation [BP] |
| CG_ff_promoter_n_PM_12_33_3 |
 |
 |
1 |
0.5 |
1.30E-04 |
PLTP,
SLC27A5 |
vitamin E biosynthetic process [BP],
cholate-CoA ligase activity [MF] |
| CG_ff_promoter_n_PM_20_6_58 |
 |
 |
2 |
1.0 |
5.29E-05 |
SMG1,
EDC3,
MED24,
RPS29,
SSR1,
MED4,
CPSF7,
EXOSC1,
POLR3H,
RPS25 |
gene expression [BP] |
| CG_ff_promoter_n_PM_12_191_4 |
 |
 |
3 |
1.0 |
1.08E-04 |
OCA2 |
arsenite transport [BP],
tyrosine transport [BP],
L-tyrosine transmembrane transporter activity [MF] |
| CG_ff_promoter_n_PM_12_39_9 |
 |
 |
1 |
0.5 |
2.44E-04 |
CTGF |
organ senescence [BP],
response to anoxia [BP] |
| CG_ff_promoter_n_PM_14_71_15 |
 |
 |
2 |
1.0 |
6.02E-05 |
SCNN1A,
CDC25C |
WW domain binding [MF] |
| CG_ff_promoter_n_PM_16_22_15 |
 |
 |
1 |
0.5 |
3.06E-05 |
PITPNA |
phosphatidylcholine transporter activity [MF],
stearic acid binding [MF] |
| CG_ff_promoter_n_PM_14_4_11 |
 |
 |
2 |
1.0 |
6.00E-05 |
RPUSD1,
E2F1,
PUS7,
CEBPA |
pseudouridine synthase activity [MF],
pseudouridine synthesis [BP],
Rb-E2F complex [CC] |
| CG_ff_promoter_n_PM_14_53_8 |
 |
 |
2 |
1.0 |
2.45E-05 |
PLA2G3,
TUBD1,
SEPT4,
RABL5,
PITPNA,
BAD |
sperm mitochondrion organization [BP],
GTP binding [MF],
positive regulation of mitochondrial membrane potential [BP],
stearic acid binding [MF],
cellular response to chromate [BP],
phosphatidylcholine transporter activity [MF],
centriole [CC] |
| CG_ff_promoter_n_PM_12_17_3 |
 |
 |
1 |
0.5 |
2.32E-04 |
SPG20 |
negative regulation of collateral sprouting in absence of injury [BP] |
| CG_ff_promoter_n_PM_12_121_11 |
 |
 |
2 |
1.0 |
4.52E-05 |
HEG1 |
lymph circulation [BP] |
| CG_ff_promoter_n_PM_12_150_4 |
 |
 |
1 |
0.5 |
1.01E-04 |
BDNF,
RLBP1 |
response to fluoxetine [BP],
response to anesthetic [BP],
11-cis retinal binding [MF],
neurotrophin TRKB receptor binding [MF] |
| CG_ff_promoter_n_PM_18_30_82 |
 |
 |
2 |
1.0 |
6.91E-05 |
CNOT4,
PABPC1 |
nuclear-transcribed mRNA poly(A) tail shortening [BP] |
| CG_ff_promoter_n_PM_12_90_4 |
 |
 |
2 |
1.0 |
1.05E-04 |
TNP1,
IL18 |
positive regulation of male germ cell proliferation [BP],
fertilization, exchange of chromosomal proteins [BP],
positive regulation of tissue remodeling [BP] |
| CG_ff_promoter_n_PM_16_17_16 |
 |
 |
2 |
1.0 |
4.56E-05 |
SLX4 |
ERCC4-ERCC1 complex [CC],
Holliday junction resolvase complex [CC] |
| CG_ff_promoter_n_PM_12_15_12 |
 |
 |
2 |
1.0 |
2.74E-05 |
GLUL |
dynein light chain binding [MF] |
| CG_ff_promoter_n_PM_16_9_28 |
 |
 |
2 |
1.0 |
4.90E-05 |
CENPV |
carbon-sulfur lyase activity [MF] |
| CG_ff_promoter_n_PM_14_75_15 |
 |
 |
1 |
0.5 |
5.71E-05 |
ABCA3 |
alveolar lamellar body membrane [CC] |
| CG_ff_promoter_n_PM_16_1_8 |
 |
 |
2 |
1.0 |
3.15E-05 |
HDAC5 |
regulation of myotube differentiation [BP] |
| CG_ff_promoter_n_PM_12_160_6 |
 |
 |
2 |
1.0 |
1.79E-04 |
REV1 |
deoxycytidyl transferase activity [MF],
error-prone translesion synthesis [BP] |
| CG_ff_promoter_n_PM_12_126_8 |
 |
 |
3 |
1.0 |
8.19E-05 |
DHPS,
TAS1R2 |
sweet taste receptor activity [MF],
sensory perception of sweet taste [BP],
detection of chemical stimulus involved in sensory perception of sweet taste [BP],
peptidyl-lysine modification to hypusine [BP],
deoxyhypusine biosynthetic process from spermidine [BP],
deoxyhypusine synthase activity [MF] |
| CG_ff_promoter_n_PM_14_37_4 |
 |
 |
1 |
0.5 |
5.31E-05 |
NES,
GALNS |
positive regulation of intermediate filament depolymerization [BP],
N-acetylgalactosamine-6-sulfatase activity [MF] |
| CG_ff_promoter_n_PM_12_18_6 |
 |
 |
2 |
1.0 |
4.58E-05 |
MB,
SNX8 |
early endosome to Golgi transport [BP],
slow-twitch skeletal muscle fiber contraction [BP] |
| CG_ff_promoter_n_PM_12_94_11 |
 |
 |
2 |
1.0 |
1.77E-04 |
HTR1B |
cellular response to temperature stimulus [BP] |
| CG_ff_promoter_n_PM_12_29_6 |
 |
 |
1 |
0.5 |
1.68E-04 |
UCN,
BRF1,
NSMF |
transcription factor TFIIIB complex [CC],
apical dendrite [CC],
gastric emptying [BP],
perikaryon [CC] |
| CG_ff_promoter_n_PM_18_16_20 |
 |
 |
2 |
1.0 |
2.38E-05 |
TAF6,
MED1,
RAF1,
NCOA2,
EIF2AK1 |
negative regulation of cell proliferation [BP],
heart development [BP],
thyroid hormone receptor coactivator activity [MF],
ligand-dependent nuclear receptor binding [MF] |
| CG_ff_promoter_n_PM_16_11_9 |
 |
 |
1 |
0.5 |
2.76E-05 |
NT5C3 |
2'-phosphotransferase activity [MF] |
| CG_ff_promoter_n_PM_12_14_5 |
 |
 |
2 |
0.5 |
4.98E-04 |
ATP6V1E2,
NCF2 |
acrosomal vesicle [CC],
phagosome maturation [BP] |
| CG_ff_promoter_n_PM_12_183_6 |
 |
 |
1 |
0.5 |
2.19E-04 |
SLC39A6 |
zinc ion transmembrane import [BP] |
| CG_ff_promoter_n_PM_14_67_7 |
 |
 |
1 |
0.5 |
1.77E-05 |
AIFM2,
HSD17B11,
NHP2,
EXOSC10 |
lipid particle [CC],
nuclear retention of unspliced pre-mRNA at the site of transcription [BP],
rRNA pseudouridine synthesis [BP] |
| CG_ff_promoter_n_PM_12_11_7 |
 |
 |
1 |
0.5 |
2.34E-04 |
ITGA5,
SCNN1A,
SOX18 |
vascular endothelial growth factor receptor 2 binding [MF],
endocardium formation [BP],
external side of plasma membrane [CC],
stem cell fate specification [BP],
alphav-beta3 integrin-vitronectin complex [CC] |
| CG_ff_promoter_n_PM_12_95_3 |
 |
 |
1 |
0.5 |
9.91E-06 |
CYP24A1,
TRMT61B,
AKR7A2 |
25-hydroxycholecalciferol-24-hydroxylase activity [MF],
1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity [MF],
mitochondrial tRNA methylation [BP],
phenanthrene-9,10-epoxide hydrolase activity [MF] |
| CG_ff_promoter_n_PM_18_5_30 |
 |
 |
2 |
1.0 |
4.31E-05 |
CACNB4,
DIABLO |
internal side of plasma membrane [CC] |
| CG_ff_promoter_n_PM_12_174_5 |
 |
 |
1 |
0.5 |
2.10E-04 |
NMNAT3 |
nicotinamide-nucleotide adenylyltransferase activity [MF] |
| CG_ff_promoter_n_PM_16_38_9 |
 |
 |
1 |
0.5 |
5.91E-05 |
CYP2D6 |
negative regulation of cellular organofluorine metabolic process [BP] |
| CG_ff_promoter_n_PM_16_46_12 |
 |
 |
2 |
1.0 |
7.52E-05 |
ASTL,
MMP27 |
glutamic-type peptidase activity [MF],
cortical granule [CC],
metalloendopeptidase activity [MF] |
| CG_ff_promoter_n_PM_12_31_3 |
 |
 |
1 |
0.5 |
1.58E-04 |
APRT |
adenine binding [MF],
adenine phosphoribosyltransferase activity [MF] |
| CG_ff_promoter_n_PM_12_98_6 |
 |
 |
1 |
0.5 |
2.47E-04 |
PPM1F |
negative regulation of protein kinase activity by regulation of protein phosphorylation [BP] |
| CG_ff_promoter_n_PM_18_15_19 |
 |
 |
1 |
0.5 |
3.15E-05 |
COG4,
SNX8 |
early endosome to Golgi transport [BP],
Golgi vesicle prefusion complex stabilization [BP] |
| CG_ff_promoter_n_PM_12_148_6 |
 |
 |
2 |
1.0 |
1.62E-05 |
RBFOX2,
AIFM2 |
regulation of definitive erythrocyte differentiation [BP],
electron-transferring-flavoprotein dehydrogenase activity [MF] |
| CG_ff_promoter_n_PM_12_133_9 |
 |
 |
1 |
0.5 |
1.22E-04 |
NKX6-2,
GRIN2C |
neuromuscular process controlling balance [BP] |
| CG_ff_promoter_n_PM_16_44_11 |
 |
 |
1 |
0.5 |
5.04E-05 |
ERCC3,
TREH |
alpha,alpha-trehalase activity [MF],
nucleotide-excision repair, DNA duplex unwinding [BP],
trehalose catabolic process [BP],
trehalose metabolic process [BP] |
| CG_ff_promoter_n_PM_14_70_5 |
 |
 |
1 |
0.5 |
1.42E-05 |
ZRANB3,
SNX8 |
DNA rewinding [BP],
early endosome to Golgi transport [BP] |
| CG_ff_promoter_n_PM_12_3_11 |
 |
 |
2 |
1.0 |
1.50E-04 |
CASP12,
ZBTB17,
PMS2,
ZC3H12D |
endonuclease activity [MF],
endoplasmic reticulum unfolded protein response [BP] |
| CG_ff_promoter_n_PM_18_29_89 |
 |
 |
2 |
1.0 |
5.75E-05 |
DNAJC7,
AQP3,
HAS2,
DNAJB1 |
renal water absorption [BP],
chaperone cofactor-dependent protein refolding [BP] |
| CG_ff_promoter_n_PM_12_109_5 |
 |
 |
2 |
1.0 |
2.31E-04 |
GCNT4 |
inter-male aggressive behavior [BP] |
| CG_ff_promoter_n_PM_14_8_10 |
 |
 |
2 |
1.0 |
8.50E-05 |
SLC10A6,
PRPF8,
CD2BP2 |
sodium-dependent organic anion transmembrane transporter activity [MF],
U5 snRNP [CC] |
| CG_ff_promoter_n_PM_12_45_7 |
 |
 |
1 |
0.5 |
2.86E-05 |
SGSH |
N-sulfoglucosamine sulfohydrolase activity [MF] |
| CG_ff_promoter_n_PM_12_192_8 |
 |
 |
1 |
0.5 |
7.20E-05 |
IP6K3,
TECPR1 |
inositol hexakisphosphate 6-kinase activity [MF],
autophagic vacuole fusion [BP] |
| CG_ff_promoter_n_PM_12_27_7 |
 |
 |
1 |
0.5 |
1.69E-05 |
ADAMTS8 |
low affinity phosphate transmembrane transporter activity [MF] |
| CG_ff_promoter_n_PM_12_168_8 |
 |
 |
2 |
1.0 |
4.33E-05 |
SLC33A1,
SUCLG2 |
acetyl-CoA transporter activity [MF],
acetyl-CoA transport [BP],
succinate-CoA ligase (GDP-forming) activity [MF] |
| CG_ff_promoter_n_PM_12_35_6 |
 |
 |
1 |
0.5 |
5.30E-05 |
PTK2 |
netrin-activated signaling pathway [BP],
cellular chloride ion homeostasis [BP] |
| CG_ff_promoter_n_PM_12_81_8 |
 |
 |
1 |
0.5 |
1.49E-04 |
FASN,
CDK5,
SPAG8,
EIF4E |
3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF],
3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF],
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF],
[acyl-carrier-protein] S-acetyltransferase activity [MF],
eukaryotic initiation factor 4G binding [MF],
positive regulation of protein binding [BP],
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF],
acetylcholine receptor activator activity [MF] |
| CG_ff_promoter_n_PM_12_97_6 |
 |
 |
1 |
0.5 |
1.57E-04 |
TMEM173,
MB,
FGFR2 |
cyclic-di-GMP binding [MF],
slow-twitch skeletal muscle fiber contraction [BP],
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP],
fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP],
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP],
coronal suture morphogenesis [BP] |
| CG_ff_promoter_n_PM_12_52_7 |
 |
 |
1 |
0.5 |
2.49E-04 |
RHOA |
skeletal muscle tissue development [BP] |
| CG_ff_promoter_n_PM_18_26_31 |
 |
 |
1 |
0.5 |
3.83E-05 |
MKNK2,
CIT,
TNIK,
GPX1,
AKT2,
GPLD1,
BRAF,
KRT10,
STK38,
LENG9,
APOA2,
MAP4K1 |
catalytic activity [MF],
protein serine/threonine kinase activity [MF],
protein kinase activity [MF],
cellular response to calcium ion [BP],
protein oxidation [BP],
kinase activity [MF],
triglyceride metabolic process [BP],
high-density lipoprotein particle clearance [BP] |
| CG_ff_promoter_n_PM_14_21_6 |
 |
 |
1 |
0.5 |
1.30E-04 |
GLRX2 |
arsenate reductase (glutaredoxin) activity [MF],
DNA protection [BP] |
| CG_ff_promoter_n_PM_12_179_6 |
 |
 |
1 |
0.5 |
2.66E-05 |
SLC36A4 |
tryptophan transport [BP] |
| CG_ff_promoter_n_PM_12_74_4 |
 |
 |
1 |
0.5 |
4.72E-05 |
BNIP3,
SORT1 |
neurotensin receptor activity, non-G-protein coupled [MF],
cellular response to cobalt ion [BP] |
| CG_ff_promoter_n_PM_14_45_11 |
 |
 |
3 |
1.0 |
5.79E-05 |
COL7A1,
P2RX1 |
external side of cell outer membrane [CC],
collagen type VII [CC] |
| CG_ff_promoter_n_PM_12_187_4 |
 |
 |
1 |
0.5 |
5.28E-05 |
PMCH |
melanin-concentrating hormone activity [MF] |
| CG_ff_promoter_n_PM_12_47_5 |
 |
 |
1 |
0.5 |
2.81E-04 |
SHPK |
cellular response to interleukin-13 [BP],
sedoheptulokinase activity [MF] |
| CG_ff_promoter_n_PM_12_157_6 |
 |
 |
1 |
0.5 |
1.90E-04 |
OSM |
oncostatin-M receptor binding [MF] |
| CG_ff_promoter_n_PM_12_116_4 |
 |
 |
1 |
0.5 |
1.20E-05 |
GGACT |
gamma-glutamylcyclotransferase activity [MF] |
| CG_ff_promoter_n_PM_16_12_7 |
 |
 |
1 |
0.5 |
2.72E-05 |
PC,
HLCS,
TOP1MT,
POLRMT |
biotin binding [MF],
biotin-[acetyl-CoA-carboxylase] ligase activity [MF],
biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [MF],
biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [MF],
protein biotinylation [BP],
mitochondrial matrix [CC],
biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [MF],
mitochondrial nucleoid [CC],
biotin-protein ligase activity [MF],
histone biotinylation [BP],
pyruvate carboxylase activity [MF] |
| CG_ff_promoter_n_PM_14_54_6 |
 |
 |
1 |
0.5 |
4.89E-05 |
LPCAT3,
TOP3A |
DNA topoisomerase type I activity [MF],
1-acylglycerophosphocholine O-acyltransferase activity [MF] |
| CG_ff_promoter_n_PM_12_59_6 |
 |
 |
2 |
1.0 |
4.14E-05 |
USP34,
ATXN3,
ITPK1 |
inositol tetrakisphosphate 1-kinase activity [MF],
inositol-1,3,4-trisphosphate 6-kinase activity [MF],
ubiquitin-specific protease activity [MF],
inositol-1,3,4-trisphosphate 5-kinase activity [MF] |
| CG_ff_promoter_n_PM_12_189_6 |
 |
 |
1 |
0.5 |
7.68E-05 |
CHCHD4,
PC |
protein import into mitochondrial intermembrane space [BP],
pyruvate carboxylase activity [MF] |
| CG_ff_promoter_n_PM_20_17_13 |
 |
 |
1 |
0.5 |
4.97E-05 |
ISYNA1 |
inositol-3-phosphate synthase activity [MF] |
| CG_ff_promoter_n_PM_20_18_41 |
 |
 |
2 |
1.0 |
2.81E-05 |
TEX10,
KANSL1 |
MLL1 complex [CC] |
| CG_ff_promoter_n_PM_20_30_33 |
 |
 |
2 |
1.0 |
1.05E-04 |
TIA1,
PABPC4 |
poly(A) RNA binding [MF] |
| CG_ff_promoter_n_PM_14_12_6 |
 |
 |
2 |
1.0 |
4.74E-05 |
BAZ2A |
heterochromatin assembly involved in chromatin silencing [BP] |
| CG_ff_promoter_n_PM_12_165_7 |
 |
 |
1 |
0.5 |
4.32E-05 |
CCND3,
SLC23A1,
CDK19,
MAK,
SRPK2,
ANKLE2 |
dehydroascorbic acid transport [BP],
mitotic nuclear envelope reassembly [BP],
protein serine/threonine kinase activity [MF],
protein kinase activity [MF],
cyclin-dependent protein kinase activity [MF],
nuclear speck organization [BP] |
| CG_ff_promoter_n_PM_16_27_15 |
 |
 |
2 |
1.0 |
3.07E-05 |
CEP41,
YWHAG,
TUBGCP2 |
G2/M transition of mitotic cell cycle [BP] |
| CG_ff_promoter_n_PM_16_24_15 |
 |
 |
2 |
1.0 |
7.57E-05 |
PRKAB2,
PIK3CB,
EIF2B1,
NFS1,
FGF8,
CPT1B |
response to peptide hormone stimulus [BP],
cell migration involved in mesendoderm migration [BP],
insulin receptor signaling pathway [BP],
carnitine shuttle [BP],
regulation of fatty acid oxidation [BP],
cysteine desulfurase activity [MF] |
| CG_ff_promoter_n_PM_12_49_7 |
 |
 |
1 |
0.5 |
8.01E-05 |
TIA1,
EIF4A3 |
poly(A) RNA binding [MF],
regulation of mRNA splicing, via spliceosome [BP] |
| CG_ff_promoter_n_PM_12_10_6 |
 |
 |
1 |
0.5 |
4.83E-05 |
CTSL2,
XPNPEP1 |
aminopeptidase activity [MF] |
| CG_ff_promoter_n_PM_12_101_10 |
 |
 |
1 |
0.5 |
2.44E-05 |
LPXN |
negative regulation of B cell receptor signaling pathway [BP] |
| CG_ff_promoter_n_PM_14_42_5 |
 |
 |
1 |
0.5 |
6.00E-05 |
GCN1L1,
EIF4E |
eukaryotic initiation factor 4G binding [MF],
translation factor activity, nucleic acid binding [MF] |
| CG_ff_promoter_n_PM_12_66_8 |
 |
 |
2 |
1.0 |
9.60E-05 |
CDK5,
RANGAP1 |
negative regulation of protein export from nucleus [BP] |
| CG_ff_promoter_n_PM_16_29_15 |
 |
 |
2 |
1.0 |
7.01E-05 |
FTCD |
formimidoyltetrahydrofolate cyclodeaminase activity [MF],
glutamate formimidoyltransferase activity [MF] |
| CG_ff_promoter_n_PM_12_118_9 |
 |
 |
2 |
0.5 |
2.67E-04 |
DBT,
DDX28,
UBC,
PTK2 |
hypothalamus gonadotrophin-releasing hormone neuron development [BP],
dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [MF],
netrin-activated signaling pathway [BP],
mitochondrial nucleoid [CC] |
| CG_ff_promoter_n_PM_12_130_12 |
 |
 |
1 |
0.5 |
3.38E-05 |
FECH,
CEBPA |
detection of UV [BP],
response to vitamin B2 [BP] |
| CG_ff_promoter_n_PM_14_34_3 |
 |
 |
1 |
0.5 |
3.24E-05 |
PYCARD,
SBDS |
positive regulation of antigen processing and presentation of peptide antigen via MHC class II [BP],
Pyrin domain binding [MF],
mitotic spindle stabilization [BP],
myeloid dendritic cell activation involved in immune response [BP] |
| CG_ff_promoter_n_PM_14_2_9 |
 |
 |
1 |
0.5 |
5.12E-05 |
GSS,
GTF2F1,
EEF1A2,
EIF4G2 |
transcription factor TFIIF complex [CC],
glutathione synthase activity [MF],
translation factor activity, nucleic acid binding [MF] |
| CG_ff_promoter_n_PM_12_167_9 |
 |
 |
2 |
1.0 |
4.66E-05 |
MAP4,
MCCC1,
EXOSC5,
POLR3C |
methylcrotonoyl-CoA carboxylase activity [MF],
biotin metabolic process [BP],
microtubule sliding [BP],
defense response to virus [BP] |
| CG_ff_promoter_n_PM_16_40_19 |
 |
 |
1 |
0.5 |
3.01E-05 |
CRYZL1,
DNMT1,
TP53I3,
STAT5B,
HDAC2,
GNGT2,
CITED1,
GUCA1B,
TULP1 |
phototransduction [BP],
response to interleukin-2 [BP],
NADPH:quinone reductase activity [MF],
replication fork [CC] |
| CG_ff_promoter_n_PM_12_93_8 |
 |
 |
1 |
0.5 |
4.10E-05 |
DDX58,
HDAC2,
EPB42,
CDK17,
BBS10,
SACS,
PBK,
ACTA2 |
ATP binding [MF],
hippocampus development [BP] |
| CG_ff_promoter_n_PM_12_140_4 |
 |
 |
1 |
0.5 |
1.48E-04 |
MEX3D |
mRNA localization resulting in posttranscriptional regulation of gene expression [BP] |
| CG_ff_promoter_n_PM_14_18_19 |
 |
 |
2 |
1.0 |
9.81E-06 |
STAR |
cellular response to luteinizing hormone stimulus [BP],
insecticide metabolic process [BP] |
| CG_ff_promoter_n_PM_12_180_4 |
 |
 |
1 |
0.5 |
1.20E-04 |
SGSH,
DOCK7,
SLC10A6,
SMC1A |
mitotic spindle organization [BP],
microtubule cytoskeleton organization [BP],
sodium-dependent organic anion transmembrane transporter activity [MF],
N-sulfoglucosamine sulfohydrolase activity [MF],
sodium-dependent organic anion transport [BP],
cohesin core heterodimer [CC] |
| CG_ff_promoter_n_PM_14_60_7 |
 |
 |
2 |
1.0 |
3.34E-05 |
ERCC3,
TRIM27 |
nucleotide-excision repair, DNA duplex unwinding [BP],
negative regulation of interleukin-2 secretion [BP] |
| CG_ff_promoter_n_PM_12_41_13 |
 |
 |
2 |
1.0 |
2.25E-05 |
EHMT2,
KIF5B |
DNA methylation on cytosine within a CG sequence [BP],
stress granule disassembly [BP] |
| CG_ff_promoter_n_PM_12_26_4 |
 |
 |
1 |
0.5 |
5.53E-05 |
CCT6B,
SCAP |
unfolded protein binding [MF] |
| CG_ff_promoter_n_PM_20_22_43 |
 |
 |
2 |
1.0 |
3.17E-05 |
HDC,
ENTPD5 |
histidine decarboxylase activity [MF],
guanosine-diphosphatase activity [MF] |
| CG_ff_promoter_n_PM_12_57_6 |
 |
 |
1 |
0.5 |
1.11E-04 |
IL5,
PSIP1,
KARS |
lysyl-tRNA aminoacylation [BP],
supercoiled DNA binding [MF],
positive regulation of eosinophil differentiation [BP],
lysine-tRNA ligase activity [MF] |
| CG_ff_promoter_n_PM_12_149_6 |
 |
 |
1 |
0.5 |
4.55E-04 |
HNF1B |
mesonephric duct formation [BP],
hepatoblast differentiation [BP],
pronephric nephron tubule development [BP],
regulation of pronephros size [BP] |
| CG_ff_promoter_n_PM_12_77_6 |
 |
 |
2 |
1.0 |
2.89E-05 |
SIN3A,
BST2,
SRPK2 |
negative regulation of plasmacytoid dendritic cell cytokine production [BP],
negative regulation of egress of virus within host cell [BP],
response to methylglyoxal [BP],
nuclear speck organization [BP],
negative regulation of histone H3-K27 acetylation [BP],
negative regulation of viral genome replication [BP] |
| CG_ff_promoter_n_PM_20_29_51 |
 |
 |
2 |
1.0 |
6.48E-05 |
FNBP1,
AAK1,
EPS15L1,
ERCC2,
HSPD1 |
cyclin-dependent protein kinase activating kinase holoenzyme complex [CC],
coated pit [CC] |
| CG_ff_promoter_n_PM_14_66_8 |
 |
 |
2 |
1.0 |
4.82E-05 |
CLPX,
CEBPA,
POLRMT |
mitochondrial endopeptidase Clp complex [CC],
response to vitamin B2 [BP],
mitochondrial nucleoid [CC] |
| CG_ff_promoter_n_PM_12_65_4 |
 |
 |
1 |
0.5 |
1.15E-04 |
XBP1,
AK2 |
serotonin secretion, neurotransmission [BP],
sperm mitochondrial sheath [CC],
epithelial cell maturation involved in salivary gland development [BP] |
| CG_ff_promoter_n_PM_14_33_2 |
 |
 |
1 |
0.5 |
3.33E-05 |
ZC3H3,
HVCN1,
SETX,
GDE1,
SRSF9 |
mRNA export from nucleus [BP],
mRNA 3'-end processing [BP],
voltage-gated proton channel activity [MF],
termination of RNA polymerase II transcription [BP],
regulation of mRNA export from nucleus [BP],
glycerophosphoinositol glycerophosphodiesterase activity [MF] |
| CG_ff_promoter_n_PM_12_110_6 |
 |
 |
1 |
0.5 |
1.21E-04 |
CARD8,
ARL3 |
NACHT domain binding [MF],
spindle microtubule [CC] |
| CG_ff_promoter_n_PM_18_22_22 |
 |
 |
2 |
1.0 |
5.51E-05 |
PPAP2A |
intracellular steroid hormone receptor signaling pathway [BP],
androgen receptor signaling pathway [BP] |
| CG_ff_promoter_n_PM_12_62_13 |
 |
 |
2 |
1.0 |
1.60E-04 |
HDDC3,
DSC3,
PRM2,
TNIP2 |
protein stabilization [BP],
chromosome condensation [BP],
guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF] |
| CG_ff_promoter_n_PM_20_4_31 |
 |
 |
1 |
0.5 |
5.80E-05 |
STIL,
ARAP1,
CDC27,
IMPDH1,
UCK1,
CNBP,
LATS1,
AURKA,
HOMER1,
STC2,
CCBL1,
CNOT1,
MYH3 |
cytosol [CC],
regulation of store-operated calcium entry [BP] |
| CG_ff_promoter_n_PM_14_10_8 |
 |
 |
2 |
1.0 |
1.08E-04 |
ANXA5,
APOA4 |
eukaryotic cell surface binding [MF] |
| CG_ff_promoter_n_PM_12_159_6 |
 |
 |
2 |
1.0 |
2.53E-04 |
HEYL,
KRT84,
KRT6C,
KRT71,
KRT6B |
structural molecule activity [MF],
keratin filament [CC],
intermediate filament [CC],
AF-1 domain binding [MF] |
| CG_ff_promoter_n_PM_12_132_10 |
 |
 |
2 |
1.0 |
6.40E-05 |
MTOR,
PHYH,
DNMT3A |
S-adenosylhomocysteine metabolic process [BP],
methyl-branched fatty acid metabolic process [BP],
DNA methylation on cytosine within a CG sequence [BP],
regulation of carbohydrate utilization [BP],
response to amino acid stimulus [BP],
phytanoyl-CoA dioxygenase activity [MF],
C-5 methylation of cytosine [BP],
S-adenosylmethioninamine metabolic process [BP],
TFIIIC-class transcription factor binding [MF],
mTOR-FKBP12-rapamycin complex [CC],
DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [MF] |
| CG_ff_promoter_n_PM_12_22_5 |
 |
 |
1 |
0.5 |
1.14E-04 |
SHARPIN,
SDS,
BDH2 |
response to cobalamin [BP],
regulation of CD40 signaling pathway [BP],
3-hydroxybutyrate dehydrogenase activity [MF],
L-threonine ammonia-lyase activity [MF],
siderophore biosynthetic process [BP] |
| CG_ff_promoter_n_PM_12_53_3 |
 |
 |
1 |
0.5 |
1.54E-04 |
PDE5A |
positive regulation of oocyte development [BP],
negative regulation of cardiac muscle contraction [BP] |
| CG_ff_promoter_n_PM_18_28_27 |
 |
 |
2 |
1.0 |
8.74E-05 |
KCNE1 |
protein N-linked glycosylation [BP] |
| CG_ff_promoter_n_PM_20_14_39 |
 |
 |
2 |
1.0 |
4.38E-05 |
SNW1,
CCNT1 |
positive transcription elongation factor complex b [CC] |
| CG_ff_promoter_n_PM_14_40_13 |
 |
 |
2 |
1.0 |
5.49E-05 |
PGM2L1 |
glucose-1,6-bisphosphate synthase activity [MF] |
| CG_ff_promoter_n_PM_12_171_8 |
 |
 |
1 |
0.5 |
1.37E-04 |
ADA,
IMPDH1 |
purine ribonucleoside monophosphate biosynthetic process [BP],
purine nucleobase metabolic process [BP] |
| CG_ff_promoter_n_PM_12_145_3 |
 |
 |
2 |
1.0 |
2.11E-04 |
CSAD,
TFF3,
DHPS |
apical lamina of hyaline layer [CC],
deoxyhypusine synthase activity [MF],
sulfinoalanine decarboxylase activity [MF],
deoxyhypusine biosynthetic process from spermidine [BP] |
| CG_ff_promoter_n_PM_18_21_38 |
 |
 |
2 |
1.0 |
9.17E-05 |
EEF1D,
HLA-DRB1,
EEF1G |
eukaryotic translation elongation factor 1 complex [CC],
translation elongation factor activity [MF],
inflammatory response to antigenic stimulus [BP] |
| CG_ff_promoter_n_PM_12_131_9 |
 |
 |
3 |
1.0 |
2.86E-04 |
KDM2B,
NACC2 |
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP],
initiation of neural tube closure [BP] |
| CG_ff_promoter_n_PM_12_69_8 |
 |
 |
1 |
0.5 |
2.79E-04 |
NFAM1,
NACA,
TRPM1,
TAS2R14 |
positive regulation of B cell receptor signaling pathway [BP],
nascent polypeptide-associated complex [CC],
bitter taste receptor activity [MF],
negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP],
positive regulation of skeletal muscle tissue growth [BP],
new growing cell tip [CC] |
| CG_ff_promoter_n_PM_12_104_5 |
 |
 |
2 |
1.0 |
6.83E-05 |
RETSAT,
ROCK2,
SLC19A1,
FASTK |
all-trans-retinol 13,14-reductase activity [MF],
Fas-activated serine/threonine kinase activity [MF],
methotrexate transport [BP],
methotrexate transporter activity [MF],
positive regulation of centrosome duplication [BP] |
| CG_ff_promoter_n_PM_18_9_25 |
 |
 |
2 |
1.0 |
6.28E-05 |
LRRC59,
LRPPRC,
POLRMT |
mitochondrial nucleoid [CC] |
| CG_ff_promoter_n_PM_20_5_34 |
 |
 |
2 |
1.0 |
5.68E-05 |
PABPC4,
PABPC1 |
poly(A) RNA binding [MF] |
| CG_ff_promoter_n_PM_14_24_10 |
 |
 |
2 |
1.0 |
8.37E-05 |
HPD |
4-hydroxyphenylpyruvate dioxygenase activity [MF] |
| CG_ff_promoter_n_PM_12_63_5 |
 |
 |
2 |
0.5 |
1.65E-04 |
SARS2,
PAPSS1 |
sulfate adenylyltransferase (ATP) activity [MF],
serine-tRNA ligase activity [MF],
adenylylsulfate kinase activity [MF],
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [BP] |
| CG_ff_promoter_n_PM_12_7_10 |
 |
 |
1 |
0.5 |
3.32E-05 |
TOP2A,
RPE65 |
positive regulation of retroviral genome replication [BP],
retinal isomerase activity [MF],
DNA topoisomerase complex (ATP-hydrolyzing) [CC],
all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [MF],
viral integration complex [CC],
all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [MF] |
| CG_ff_promoter_n_PM_20_1_74 |
 |
 |
2 |
1.0 |
3.46E-05 |
CLDN19,
CLDN3,
CLDN22 |
calcium-independent cell-cell adhesion [BP] |
| CG_ff_promoter_n_PM_14_13_4 |
 |
 |
2 |
1.0 |
3.24E-05 |
JUP |
gamma-catenin-TCF7L2 complex [CC],
structural constituent of cell wall [MF] |
| CG_ff_promoter_n_PM_12_75_6 |
 |
 |
2 |
1.0 |
2.42E-04 |
PKD1L3 |
detection of chemical stimulus involved in sensory perception of sour taste [BP],
sour taste receptor activity [MF] |
| CG_ff_promoter_n_PM_12_99_7 |
 |
 |
3 |
1.0 |
7.20E-05 |
TOLLIP,
OLR1,
DUSP1 |
interleukin-1, Type I receptor binding [MF],
interleukin-18 receptor complex [CC],
response to hydrogen peroxide [BP] |
| CG_ff_promoter_n_PM_14_51_10 |
 |
 |
2 |
1.0 |
2.05E-05 |
RANGAP1 |
positive regulation of Ran GTPase activity [BP],
Ran GTPase activator activity [MF] |
| CG_ff_promoter_n_PM_12_169_9 |
 |
 |
1 |
0.5 |
7.80E-05 |
A4GALT,
TAT |
lactosylceramide 4-alpha-galactosyltransferase activity [MF],
L-tyrosine:2-oxoglutarate aminotransferase activity [MF] |
| CG_ff_promoter_n_PM_12_55_5 |
 |
 |
2 |
1.0 |
6.95E-05 |
RHOA,
SHPK,
GRM4 |
cellular response to interleukin-13 [BP],
negative regulation of I-kappaB kinase/NF-kappaB cascade [BP],
sedoheptulokinase activity [MF],
presynaptic active zone membrane [CC] |
| CG_ff_promoter_n_PM_14_20_11 |
 |
 |
3 |
1.0 |
4.71E-05 |
HAL,
DHRS7C |
histidine ammonia-lyase activity [MF],
longitudinal sarcoplasmic reticulum [CC] |
| CG_ff_promoter_n_PM_12_184_6 |
 |
 |
1 |
0.5 |
4.65E-05 |
ANXA5 |
endothelial microparticle [CC] |
| CG_ff_promoter_n_PM_12_8_4 |
 |
 |
1 |
0.5 |
3.01E-05 |
TEX14,
CYBA,
GLMN |
hepatocyte growth factor receptor binding [MF],
smooth muscle hypertrophy [BP],
intercellular bridge organization [BP],
negative regulation of glomerular filtration by angiotensin [BP] |
| CG_ff_promoter_n_PM_20_31_38 |
 |
 |
2 |
1.0 |
5.35E-05 |
BAZ1B,
CHCHD3 |
protein complex scaffold [MF] |
| CG_ff_promoter_n_PM_12_67_5 |
 |
 |
1 |
0.5 |
1.64E-04 |
CYP2D6,
PGAM2 |
isoquinoline alkaloid metabolic process [BP],
negative regulation of cellular organofluorine metabolic process [BP],
alkaloid catabolic process [BP],
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF] |
| CG_ff_promoter_n_PM_20_12_49 |
 |
 |
1 |
0.5 |
4.66E-05 |
GCN1L1,
EEF1D |
translation factor activity, nucleic acid binding [MF] |
| CG_ff_promoter_n_PM_18_11_40 |
 |
 |
2 |
1.0 |
2.46E-05 |
LONP1 |
mitochondrial heavy strand promoter anti-sense binding [MF],
oxidation-dependent protein catabolic process [BP],
DNA polymerase binding [MF],
mitochondrial light strand promoter anti-sense binding [MF] |
| CG_ff_promoter_n_PM_12_177_11 |
 |
 |
2 |
1.0 |
2.59E-05 |
SYNE4,
BAZ2A |
heterochromatin assembly involved in chromatin silencing [BP],
integral to nuclear outer membrane [CC] |
| CG_ff_promoter_n_PM_12_61_7 |
 |
 |
2 |
1.0 |
8.08E-05 |
PTK2,
UCN |
positive regulation of vasodilation [BP] |
| CG_ff_promoter_n_PM_14_61_10 |
 |
 |
3 |
1.0 |
1.65E-05 |
RAD54B |
DNA translocase activity [MF] |
| CG_ff_promoter_n_PM_12_48_5 |
 |
 |
1 |
0.5 |
3.62E-05 |
BUD13,
SGSH,
PLA2G16 |
RES complex [CC],
1-acyl-2-lysophosphatidylserine acylhydrolase activity [MF],
N-sulfoglucosamine sulfohydrolase activity [MF],
phosphatidylserine 1-acylhydrolase activity [MF] |
| CG_ff_promoter_n_PM_16_15_20 |
 |
 |
2 |
1.0 |
1.84E-05 |
RAB3A,
MTHFR |
maintenance of presynaptic active zone structure [BP],
methylenetetrahydrofolate reductase (NADPH) activity [MF] |
| CG_ff_promoter_n_PM_12_124_10 |
 |
 |
2 |
1.0 |
1.44E-04 |
COL7A1 |
collagen type VII [CC] |
| CG_ff_promoter_n_PM_16_16_43 |
 |
 |
2 |
1.0 |
3.37E-05 |
PELI1 |
positive regulation of toll-like receptor 3 signaling pathway [BP] |
| CG_ff_promoter_n_PM_12_40_10 |
 |
 |
1 |
0.5 |
5.03E-05 |
GLRX,
PTGES2 |
protein disulfide oxidoreductase activity [MF] |
| CG_ff_promoter_n_PM_12_78_11 |
 |
 |
1 |
0.5 |
1.85E-05 |
KCNE1 |
positive regulation of potassium ion transmembrane transport [BP] |
| CG_ff_promoter_n_PM_12_147_12 |
 |
 |
1 |
0.5 |
1.25E-04 |
USP22,
ABCG2 |
xenobiotic-transporting ATPase activity [MF],
SAGA complex [CC] |
| CG_ff_promoter_n_PM_14_48_9 |
 |
 |
2 |
1.0 |
5.74E-05 |
SUMO1,
KPNA1,
TNPO2 |
nuclear localization sequence binding [MF],
nuclear pore [CC] |
| CG_ff_promoter_n_PM_18_20_21 |
 |
 |
1 |
0.5 |
5.28E-05 |
SERINC1,
SPICE1 |
regulation of centriole replication [BP],
phosphatidylserine metabolic process [BP] |
| CG_ff_promoter_n_PM_12_64_9 |
 |
 |
2 |
0.5 |
4.38E-05 |
BICD2 |
minus-end-directed organelle transport along microtubule [BP] |
| CG_ff_promoter_n_PM_16_32_17 |
 |
 |
2 |
1.0 |
1.95E-05 |
BAZ1B |
vitamin D receptor activator activity [MF],
DNA replication-dependent nucleosome disassembly [BP] |
| CG_ff_promoter_n_PM_12_68_12 |
 |
 |
2 |
1.0 |
3.09E-05 |
HLCS,
PGGT1B |
protein biotinylation [BP],
CAAX-protein geranylgeranyltransferase complex [CC],
histone biotinylation [BP] |
| CG_ff_promoter_n_PM_12_137_9 |
 |
 |
1 |
0.5 |
3.49E-04 |
MZT2A,
TUBGCP6,
GBA,
ST6GALNAC6 |
ceramide biosynthetic process [BP],
gamma-tubulin ring complex [CC],
glycosylceramide metabolic process [BP] |
| CG_ff_promoter_n_PM_18_25_29 |
 |
 |
2 |
1.0 |
4.44E-05 |
NUDT5,
ZER1 |
D-ribose catabolic process [BP],
vacuolar proton-transporting V-type ATPase, V1 domain [CC] |
| CG_ff_promoter_n_PM_12_175_4 |
 |
 |
1 |
0.5 |
1.28E-04 |
IPMK,
M6PR,
CYB561 |
transmembrane electron transfer carrier [MF],
inositol tetrakisphosphate 3-kinase activity [MF],
inositol-1,4,5-trisphosphate 6-kinase activity [MF],
mannose transmembrane transporter activity [MF] |
| CG_ff_promoter_n_PM_14_9_2 |
 |
 |
1 |
0.5 |
2.06E-05 |
UROC1 |
urocanate hydratase activity [MF] |
| CG_ff_promoter_n_PM_16_33_4 |
 |
 |
1 |
0.5 |
6.80E-05 |
CDIPT |
CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [MF] |
| CG_ff_promoter_n_PM_12_135_6 |
 |
 |
1 |
0.5 |
4.11E-05 |
PMM1,
DNAJC28,
BAK1,
IPMK |
B cell negative selection [BP],
mannose biosynthetic process [BP],
inositol tetrakisphosphate 3-kinase activity [MF],
inositol-1,4,5-trisphosphate 6-kinase activity [MF],
response to mycotoxin [BP],
heat shock protein binding [MF],
phosphomannomutase activity [MF] |
| CG_ff_promoter_n_PM_12_146_5 |
 |
 |
1 |
0.5 |
8.85E-06 |
ARNT,
PTGIS |
aryl hydrocarbon receptor activity [MF],
cellular response to hypoxia [BP],
prostaglandin-I synthase activity [MF] |
| CG_ff_promoter_n_PM_12_79_6 |
 |
 |
1 |
0.5 |
1.40E-04 |
NCOR2,
PARP10,
IGF2BP3 |
regulation of chromatin assembly [BP],
regulation of cytokine biosynthetic process [BP],
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter [BP] |
| CG_ff_promoter_n_PM_12_106_4 |
 |
 |
1 |
0.5 |
2.93E-04 |
TRPV3,
CBS |
cystathionine beta-synthase activity [MF],
cysteine biosynthetic process via cystathionine [BP],
homocysteine catabolic process [BP],
transsulfuration [BP],
cysteine biosynthetic process from serine [BP],
hydrogen sulfide biosynthetic process [BP],
negative regulation of hair cycle [BP] |
| CG_ff_promoter_n_PM_12_143_4 |
 |
 |
1 |
0.5 |
1.83E-04 |
ADPGK,
PNKP,
WT1 |
nucleotide phosphorylation [BP],
ADP-specific glucokinase activity [MF],
negative regulation of metanephric glomerular mesangial cell proliferation [BP] |
| CG_ff_promoter_n_PM_14_17_4 |
 |
 |
1 |
0.5 |
1.22E-04 |
TRIT1 |
tRNA dimethylallyltransferase activity [MF] |
| CG_ff_promoter_n_PM_18_18_23 |
 |
 |
1 |
0.5 |
2.78E-05 |
ADCY9,
ARF4,
GSK3A |
epidermal growth factor receptor signaling pathway [BP],
negative regulation of UDP-glucose catabolic process [BP] |
| CG_ff_promoter_n_PM_18_31_13 |
 |
 |
1 |
0.5 |
3.05E-05 |
PTPN7,
PPP2CA |
protein dephosphorylation [BP] |
| CG_ff_promoter_n_PM_14_11_33 |
 |
 |
1 |
0.5 |
6.16E-05 |
APRT,
ALG2 |
protein glycosylation in endoplasmic reticulum [BP],
adenine binding [MF],
adenine phosphoribosyltransferase activity [MF],
GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF] |